The US Food and Drug Administration (FDA) has approved a product known as enzalutamide (Xtandi®) to be used in a new way. The body, after an in-depth review says that it is ideal for handling a condition called prostate cancer (mHSPC). A close outlook Sometime back, the company gave its approval to the product for […]
Michael Jung
Recent Posts
VAYK Award Winning P2P Alt Real Estate Finance App Soon To Add Cryptocurrency Investment Option
Branded Legacy, Inc. Sales Increase In January
IQST – iQSTEL On Track And Gaining Momentum Toward Nasdaq Uplisting
VAYK Announces LOI To Acquire Cryptocurrency Exchange Developed By Definancial Inc.
NSAV ACQUIRES STAKE IN BQEX CRYPTO EXCHANGE AND OVER 4 MILLION REGISTERED USERS, FURTHER EXPANDING PRESENCE IN $2 TRILLION GLOBAL CRYPTOCURRENCY MARKET
Popular Post
-
JPMorgan Bringing Back Employees to Work From Office
-
Spotify Records 20% Increase in Paid Subscribers in the Second Quarter
-
Apple Employee Claims to Have Been Dismissed After Leading Movement Against Harassment
-
Solar Car Company Sono Motors Files For United States IPO
-
Ferari Poaches New CEO From Tech Industry
